Reducing Candidate Risk and Achieving Development Success with a Robust Developability Assessment Tool

BPI Contributor

August 19, 2024

3 Min View

katayama.jpg

This interview features: Derrick Katayama, Lead Scientist in Formulation Development, Samsung Biologics, from BPI Europe 2024 in Vienna, Austria.

Register or Login and hit Watch Now to view the interview now.

You May Also Like